Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document 52004XC0625(01)

    Bendrijos sprendimų dėl leidimų prekiauti vaistais sąrašas nuo 2004 5 15 iki 2004 6 15 (paskelbta sutinkamai su Tarybos Reglamento (EEB) Nr. 2309/93 12 arba 34 straipsniu)

    OL C 166, 2004 6 25, p. 2–4 (ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, NL, PL, PT, SK, SL, FI, SV)

    25.6.2004   

    LT

    Europos Sąjungos oficialusis leidinys

    C 166/2


    Bendrijos sprendimų dėl leidimų prekiauti vaistais sąrašas nuo 2004 5 15 iki 2004 6 15

    (paskelbta sutinkamai su Tarybos Reglamento (EEB) Nr. 2309/93 (1) 12 arba 34 straipsniu)

    (2004/C 166/02)

    Leidimo prekiauti išdavimas (Tarybos Reglamento (EEB) Nr. 2309/93 12 straipsnis), leidimas išduotas

    Sprendimo data

    Vaisto pavadinimas

    Leidimo savininkas

    Įrašo Bendrijos registre nr.

    Pranešimo data

    2004 6 1

    Levemir

    Novo Nordisk A/S

    Novo Allé

    DK-2880 Bagsvaerd

    EU/01/04/278/001-009

    2004 6 4

    2004 6 4

    Abilifly

    Otsuka Pharmaceutical Europe Ltd

    Common-wealth House,

    2 Chalkhill Road

    Hammersmith

    London W6 8DW

    United Kingdom

    EU/1/04/276/001-020

    2004 6 8

    2004 6 8

    TachoSil

    Nycomed Austria GMBH

    St.-Peter-Strasse 25

    A-4020 Linz

    EU/1/04/277/001-004

    2004 6 11

    2004 6 15

    Oxybutynin

    Nicobrand Limited

    189 Casteroe Road

    Coleraine

    Northerne Ireland

    EU/1/03/270/001-002

    2004 6 18

    Leidimo prekiauti pakeitimas (Tarybos Reglamento (EEB) Nr. 2309/93 12 straipsnis), leidimas pakeistas

    Sprendimo data

    Vaisto pavadinimas

    Leidimo savininkas

    Įrašo Bendrijos registre nr.

    Pranešimo data

    2004 5 19

    Protopic

    Fujisawa GmbH

    Neumarkter Str. 61

    D-81673 München

    EU/1/02/201/001-006

    2004 5 25

    2004 5 25

    Hepsera

    Gilead Sciences International Limited

    Cambridge CB1 6GT

    United Kingdom

    EU/1/03/251/001

    2004 5 27

    2004 5 26

    Viagra

    Pfizer Limited

    Sandwich

    Kent CT13 9NJ

    United Kingdom

    EU/1/98/077/001-012

    2004 6 1

    2004 5 26

    Combivir

    Glaxo Group Ltd.

    Greenford Road

    Greenford

    Middlesex UB6 0NN

    United Kingdom

    EU/1/98/058/001-002

    2004 6 1

    2004 5 26

    Ziagen

    Glaxo Group Ltd

    Greenford

    Middlesex UB6 0NN

    United Kingdom

    EU/1/99/112/001-002

    2004 6 1

    2004 5 26

    Taxotere

    Aventis Pharma S.A.

    20 avenue Raymond Aron

    92165 Antony Cedex, France

    EU/1/95/002/001-002

    2004 6 1

    2004 5 26

    TRIZIVIR

    Glaxo Group Ltd

    Greenford

    Middlesex UB6 0NN

    United Kingdom

    EU/1/00/156/001-003

    2004 6 1

    2004 6 1

    Vivanza

    Bayer AG

    D-51368 Leverkusen

    EU/1/03/249/001-012

    2004 6 7

    2004 6 1

    Levitra

    Bayer AG

    D-51368 Leverkusen

    EU/1/03/248/001-012

    2004 6 7

    2004 6 1

    Epivir

    Glaxo Group Ltd.

    Greenford Road

    Greenford

    Middlesex UB6 0NN

    United Kingdom

    EU/1/96/015/001-005

    2004 6 7

    2004 6 8

    Remicade

    Centocor B.V.

    Einsteinweg 101

    2333 CB Leiden

    Nederland

    EU/1/99/116/001-003

    2004 6 10

    2004 6 8

    Remicade

    Centocor B.V.

    Einsteinweg 101

    2333 CB Leiden

    Nederland

    EU/1/99/116/001-003

    2004 6 10

    2004 6 8

    Fuzeon

    Roche Registration Limited

    40 Broadwater Road

    Welwyn Garden City

    Hertfordshire AL7 3AY

    United Kingdom

    EU/1/03/252/001-003

    2004 6 10

    2004 6 8

    Arava

    Aventis Pharma Deutschland GmbH

    D-65926 Frankfurt am Main

    EU/1/99/118/001-010/

    2004 6 18

    2004 6 8

    Vfend

    Pfizer Limited

    Sandwich

    Kent CT13 9NJ

    United Kingdom

    EU/1/02/212/001-026

    2004 6 10

    2004 6 9

    Vfend

    Pfizer Limited

    Sandwich

    Kent CT13 9NJ

    United Kingdom

    EU/1/02/212/001-026

    2004 6 11

    2004 6 10

    Arava

    Aventis Pharma Deutschland GmbH

    D-65926 Frankfurt am Main

    EU/1/99/118/001-010/

    2004 6 16

    2004 6 10

    Viread

    Gilead Sciences International Limited

    Cambridge CB1 6GT

    United Kingdom

    EU/1/01/200/001

    2004 6 14

    2004 6 10

    Viread

    Gilead Sciences International Limited

    Cambridge CB1 6GT

    United Kingdom

    EU/1/01/200/001

    2004 6 15

    2004 6 10

    Herceptin

    Roche Registration Limited

    40 Broadwater Road

    Welwyn Garden City

    Hertfordshire AL7 3AY

    United Kingdom

    EU/1/00/145/001

    2004 6 14

    2004 6 10

    Humira

    Abbott Laboratories Ltd.

    Queenborough

    Kent ME11 5EL

    United Kingdom

    EU/1/03/256/001-006

    2004 6 14

    2004 6 10

    Trudexa

    Abbott Laboratories Ltd.

    Queenborough

    Kent ME11 5EL

    United Kingdom

    EU/1/03/257/001-006

    2004 6 14

    2004 6 15

    Xigris

    Eli Lilly Nederland B.V.

    Grootslag 1-5

    3991 RA Houten

    Nederland

    EU/1/02/225/001-002

    2004 6 17


    (1)  OL L 214 1993 m. rugpjūčio 28 d., 1 puslapis.


    Top